Hubertus von Baumbach explained

Hubertus von Baumbach
Nationality:	German
Education:	Massachusetts Institute of Technology
Occupation:	Businessman
Chairman and CEO, Boehringer Ingelheim

Hubertus von Baumbach (born 1967) is a German businessman who is the chairman and CEO of Boehringer Ingelheim, Germany's second largest pharmaceutical company.^[1]

Early life and education

The son of Erich von Baumbach and Ulrike Boehringer, Hubertus von Baumbach is also a great-grandson of the company's founder Albert Boehringer.^[2] He has a law degree and an MBA from the Massachusetts Institute of Technology.^{[3] [1]}

Career

Baumbach joined Boehringer Ingelheim in 2001.^[3]

In November 2015, it was announced that Baumbach, who had been CFO, was appointed as chief executive, succeeding Andreas Barner in June 2016.^{[2] [1]} At the time, this made him the first member of the family at the helm in 25 years.^[4] Within his first six months, he launched the biggest acquisition in the company's history (an asset swap deal with French rival Sanofi), followed by a reorganization to give the group a more decentralized divisional structure.^[5]

In his capacity at Boehringer Ingelheim, Baumbach was part of Chancellor Angela Merkel’s delegation on three state visits to China.^[6]

Other activities

Corporate boards

• Deutsche Bank, Member of the Advisory Board^[7]
• Baden-Württembergische Bank, Member of the Advisory Board
• Landesbank Baden-Württemberg (LBBW), Member of the Advisory Board^[8]
• KWS Saat, Member of the supervisory board (2007-2017)

Non-profit organizations

• Federation of German Industries (BDI), Member of the Presidium (2018-2019)^[9]
• German Chemical Industry Association (VCI), Member of the Executive Committee^[10]
• Baden-Badener Unternehmer-Gespräche (BBUG), Member of the Board of Trustees^[11]
• Cultural Foundation of the Federal States, Member of the Board of Trustees^[12]
• Städel Museum, Member of the Administration^[13] and the Board of Trustees^[14]
• Stiftung Tausendgut, Member of the Board of Trustees^[15]

Notes and References

1. Web site: Drug firm Boehringer Ingelheim on a high. 27 April 2018. handelsblatt.com. 7 November 2018.
2. News: Boehringer appoints first CEO from founding family in 25 years. Reuters. Editorial. 6 November 2015. reuters.com. 7 November 2018.
3. Web site: Board of Managing Directors - boehringer-ingelheim.com. boehringer-ingelheim.com. 7 November 2018.
4. Patricia Weiss and Maria Sheahan (November 6, 2015), Boehringer appoints first CEO from founding family in 25 years Reuters .
5. Siegfried Hofmann (April 27, 2018), Drug firm Boehringer Ingelheim on a high Handelsblatt .
6. Christian Schlesiger (September 8, 2017), Siemens-Chef Kaeser am häufigsten bei Delegationsreisen dabei Wirtschaftswoche.
7. https://geschaeftsbericht.deutsche-bank.de/2010/gb/serviceseiten/downloads/files/dbfy2010_verzeichnis_beiratsmitglieder.pdf Members of the Advisory Board, 2010
8. https://www.lbbw.de/media/investor_relations/pdf_investorrelations/2016/LBBW_Geschaeftsbericht_2015.pdf 2015 Annual Report
9. https://bdi.eu/der-bdi/organisation/praesidium/ Presidium
10. Web site: Vorstand & Präsidium - Verband der Chemischen Industrie e.V. (VCI). www.vci.de. DE. 2017-06-01.
11. https://www.bbug.de/de/ueber-uns/der-verein.php Board of Trustees
12. http://www.kulturstiftung.de/kuratorium/ Board of Trustees
13. https://www.staedelmuseum.de/en/about-stadel-museum#administration Administration
14. https://www.staedelmuseum.de/en/support Board of Trustees
15. https://stiftung-tausendgut.de/index.php/gremien.html Board of Trustees